<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.3" xml:lang="EN" article-type="rapid-communication"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Org Lett</journal-id><journal-id journal-id-type="iso-abbrev">Org Lett</journal-id><journal-id journal-id-type="publisher-id">ol</journal-id><journal-id journal-id-type="coden">orlef7</journal-id><journal-title-group><journal-title>Organic Letters</journal-title></journal-title-group><issn pub-type="ppub">1523-7060</issn><issn pub-type="epub">1523-7052</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38039188</article-id><article-id pub-id-type="pmc">PMC10729020</article-id>
<article-id pub-id-type="doi">10.1021/acs.orglett.3c03325</article-id><article-categories><subj-group><subject>Letter</subject></subj-group></article-categories><title-group><article-title>Asymmetric Dearomatization
of Phthalazines by Anion-Binding
Catalysis</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4350-4968</contrib-id><name><surname>Vel&#x000e1;zquez</surname><given-names>Marta</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath2"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1755-1525</contrib-id><name><surname>Fern&#x000e1;ndez</surname><given-names>Rosario</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath3"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1772-2723</contrib-id><name><surname>Lassaletta</surname><given-names>Jos&#x000e9; M.</given-names></name><xref rid="cor2" ref-type="other">*</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath4"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8007-4111</contrib-id><name><surname>Monge</surname><given-names>David</given-names></name><xref rid="cor3" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Departamento
de Qu&#x000ed;mica Org&#x000e1;nica, Facultad de Qu&#x000ed;mica, <institution>Universidad de Sevilla and Centro de Innovaci&#x000f3;n
en Qu&#x000ed;mica Avanzada (ORFEO-CINQA)</institution>, C/Prof. Garc&#x000ed;a Gonz&#x000e1;lez, 1, 41012 Sevilla, <country>Spain</country></aff><aff id="aff2"><label>&#x02021;</label><institution>Instituto
de Investigaciones Qu&#x000ed;micas (CSIC-US) and Centro de Innovaci&#x000f3;n
en Qu&#x000ed;mica Avanzada (ORFEO-CINQA)</institution>, Avenida Am&#x000e9;rico Vespucio, 49, 41092 Sevilla, <country>Spain</country></aff></contrib-group><author-notes><corresp id="cor3"><label>*</label>D.M.:
email, <email>dmonge@us.es</email>.</corresp><corresp id="cor1"><label>*</label>R.F.: email, <email>ffernan@us.es</email>.</corresp><corresp id="cor2"><label>*</label>J.M.L.: email, <email>jmlassa@iiq.csic.es</email>.</corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>12</month><year>2023</year></pub-date><pub-date pub-type="collection"><day>15</day><month>12</month><year>2023</year></pub-date><volume>25</volume><issue>49</issue><fpage>8797</fpage><lpage>8802</lpage><history><date date-type="received"><day>10</day><month>10</month><year>2023</year></date><date date-type="accepted"><day>29</day><month>11</month><year>2023</year></date><date date-type="rev-recd"><day>12</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>&#x000a9; 2023 The Authors. Published by American Chemical Society</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>The Authors</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ol3c03325_0009" id="ab-tgr1"/></p><p>A straightforward methodology for the enantioselective
synthesis
of 1,2-dihydrophthalazines <italic>via</italic> dearomatization of
phthalazines by anion-binding catalysis has been developed. The process
involves the Mannich-type addition of silyl ketene acetals to <italic>in situ</italic> generated <italic>N</italic>-acylphthalazinium chlorides
using a <italic>tert</italic>-leucine derived thiourea as a H-bond
donor catalyst. Ensuing selective and high-yielding transformations
provide appealing dihydro- and tetrahydro-phthalazines, phthalazones,
and piperazic acid homologues, en route to biologically relevant molecules.</p></abstract><funding-group><award-group><funding-source><institution-wrap><institution>Consejer&#x000c3;&#x000ad;a de Econom&#x000c3;&#x000ad;a, Innovaci&#x000c3;&#x000b3;n, Ciencia y Empleo, Junta de Andaluc&#x000c3;&#x000ad;a</institution><institution-id institution-id-type="doi">10.13039/501100002878</institution-id></institution-wrap></funding-source><award-id>P18-FR-3531</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>European Regional Development Fund</institution><institution-id institution-id-type="doi">10.13039/501100008530</institution-id></institution-wrap></funding-source><award-id>NA</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Ministerio de Ciencia e Innovaci&#x000c3;&#x000b3;n</institution><institution-id institution-id-type="doi">10.13039/501100004837</institution-id></institution-wrap></funding-source><award-id>PID2022-137888NB-I00</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Ministerio de Ciencia e Innovaci&#x000c3;&#x000b3;n</institution><institution-id institution-id-type="doi">10.13039/501100004837</institution-id></institution-wrap></funding-source><award-id>PID2019-106358GB-C22</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Ministerio de Ciencia e Innovaci&#x000c3;&#x000b3;n</institution><institution-id institution-id-type="doi">10.13039/501100004837</institution-id></institution-wrap></funding-source><award-id>PID2019-106358GB-C21</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Consejer&#x000c3;&#x000ad;a de Econom&#x000c3;&#x000ad;a, Innovaci&#x000c3;&#x000b3;n, Ciencia y Empleo, Junta de Andaluc&#x000c3;&#x000ad;a</institution><institution-id institution-id-type="doi">10.13039/501100002878</institution-id></institution-wrap></funding-source><award-id>US-1262867</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution>Consejer&#x000c3;&#x000ad;a de Econom&#x000c3;&#x000ad;a, Innovaci&#x000c3;&#x000b3;n, Ciencia y Empleo, Junta de Andaluc&#x000c3;&#x000ad;a</institution><institution-id institution-id-type="doi">10.13039/501100002878</institution-id></institution-wrap></funding-source><award-id>P18-FR-644</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>ol3c03325</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>ol3c03325</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><p>Benzodiazines are important
bioactive heterocycles with a wide range of applications in the pharmaceutical
and agrochemical fields.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> Among them, phthalazine
(2,3-diazanaphthalene) and dihydrophthalazine derivatives are probably
the most privileged pharmacophores (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> For example,
azelastine (a phthalazone) is an efficient histamine antagonist approved
for the treatment of allergic rhinitis<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> and dihydrophthalazine SYM2206 is an AMPA receptor modulator with
anticonvulsant activity.<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> Chiral racemic
dihydrophthalazines BAL0030543<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> and (<italic>S</italic>)-RAB1 and their analogues<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> are
potent dihydrofolate reductase inhibitors that have demonstrated activity
against antibiotic-resistant strains of <italic>Staphylococcus aureus</italic>, among other Gram-positive bacteria.</p><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Selective bioactive diazaheterocycles.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ol3c03325_0001" id="gr5" position="float"/></fig><p>On the other hand, monocyclic derivatives have
also shown interesting
bioactivities. Selected examples are cilazapril, a marketed saturated
pyridazine (piperazic acid derivative) drug for the treatment of hypertension,<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> and matlystatins, a group of potent metalloproteinase
inhibitors.<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> However, their potential as
therapeutic weapons contrasts with the scarcity of methodologies for
accessing these chiral molecules in an enantioselective fashion. In
this regard, a straightforward approach consists of the stereoselective
dearomatization of phthalazin-2-ium salts derived from readily available
phthalazines.</p><p>Several examples demonstrate the use of phthalazinium
dicyanomethanides
as stable azomethine ylides in [3 + 3] and [3 + 2] cycloaddition reactions.
These reactions are enabled by Cu(I) and iminium catalysis, respectively
(<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>A).<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> Furthermore, an <italic>N</italic>-alkyl phthalazinium
iodide was subjected to enamine catalysis for a nucleophilic dearomatization
reaction in an intramolecular version. However, only a single example
was reported (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>B).<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> Herein, we report the asymmetric
synthesis of 1,2-dihydrophthalazines through dearomatization of phthalazines
via anion-binding catalysis using H-bond donor organocatalysts (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>C). The process involves
the nucleophilic addition of silyl ketene acetals to <italic>in situ</italic> generated <italic>N</italic>-acyl-phthalazinium halides.</p><fig id="sch1" position="float"><label>Scheme 1</label><caption><title>Catalytic
Asymmetric Dearomatization of Phthalazines</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ol3c03325_0003" id="gr1" position="float"/></fig><p>Pioneered by Jacobsen,<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> anion-binding
catalysis<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> has enabled a wide range of
nucleophilic dearomatizations of mono aza-heterocycles, such as isoquinolines,
quinolines, and pyridines.<sup><xref ref-type="bibr" rid="ref13">13</xref></sup> However, attempts
to implement these methodologies in diaza-heterocycles remain challenging
due to the increased complexity associated with the presence of two
nitrogens prone to be acylated, resulting in multiple reactive positions
and thereby lower yields and side reactions. Moreover, enantioselectivities
have been often compromised. To the best of our knowledge, only quinazolines
(1,3-diazanaphthalenes) have been efficiently dearomatized with high
enantioselectivities by asymmetric anion-binding catalysis. Employing
chiral triazoles (CH-bond donors), Garc&#x000ed;a Manche&#x000f1;o
and co-workers successfully developed the dearomatization of quinazoline
through a nucleophilic C2-addition of silyl ketene acetals (up to
92% ee), while phthalazine and pyridazine underwent dearomatization
reactions with moderate enantioselectivities.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> It is worth mentioning that alternative metal-catalyzed dearomatization
of pyridazine also remains virtually unknown.</p><p>Preliminary experiments
were conducted employing phthalazine (<bold>1a</bold>) as a model
substrate, 2,2,2-trichloroethyl chloroformate
(TrocCl) as acylating reagent, and isopropyl TBS-ketene acetal <bold>2a</bold> as the nucleophile. The model reaction was initially studied
in methyl <italic>tert-</italic>butyl ether (MTBE) employing a temperature
gradient (from &#x02212;78 &#x000b0;C to room temperature over 18 h).
Although a quite insoluble phthalazinium salt was generated, a significant
background reaction took place in the absence of any catalyst (entry
1, <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>). From the
initial screening of hydrogen-bond donor (HBD) organocatalysts (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.orglett.3c03325/suppl_file/ol3c03325_si_001.pdf">Supporting Information</ext-link>), <italic>tert</italic>-leucine derived thiourea <bold>I</bold> emerged as the most promising
candidate, affording (<italic>S</italic>)-<bold>3aa</bold> in 57%
NMR-yield and 81% ee (entry 2). Organocatalyst <bold>II</bold>, featuring
a combination of <italic>tert</italic>-leucine and (1<italic>R</italic>,2<italic>R</italic>)-1,2-diaminocyclohexane scaffolds similar to
the optimal catalyst originally reported for the dearomatization of
isoquinolines,<sup><xref ref-type="bibr" rid="ref11">11</xref></sup> displayed almost no stereocontrol
(entry 3). Next, HBDs <bold>III</bold>-<bold>VII</bold>, bearing the
more rigid 2-substituted pyrrolidino amide motifs, were evaluated
(entries 4&#x02013;8). In general, these catalysts exhibited good catalytic
activities, achieving a maximum yield of 75% with thiourea <bold>IV</bold>. In accordance with a better conformational control exerted by the
2-methyl-2-phenylpyrrolidine scaffold,<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> (<italic>S</italic>)-<bold>3aa</bold> was obtained in 89% ee employing
either thiourea <bold>IV</bold> or urea <bold>V</bold> (entries 5
and 6). Remarkably, catalyst <bold>VII</bold>, featuring a more extended
&#x003c0; moiety, afforded <bold>3aa</bold> as a racemic mixture (entry
8). Other ethereal solvents (Et<sub>2</sub>O or THF) and toluene were
tolerated (entries 9&#x02013;12). However, none of them overcame the
results obtained with MTBE. The influence of the acylating reagent
on the reactivity and selectivity was further investigated (<xref rid="sch2" ref-type="scheme">Scheme <xref rid="sch2" ref-type="scheme">2</xref></xref>). In the chlorinated
series, 2-chloroethoxycarbonyl-protected adduct <bold>4aa</bold> was
obtained in lower enantioselectivity (66% ee), while only traces of
product were formed with 1,1,1-trichloromethoxycabonyl chloride <bold>5aa</bold>. Phthalazines <bold>6aa</bold> and <bold>7aa</bold>, bearing
Cbz and Ac protecting groups, were isolated in 75 and 98% yields,
albeit with lower enantioselectivities (55 and 64%, respectively).
To our delight, Bz-protected adduct <bold>8aa</bold> was obtained
with essentially the same enantioselectivity than Troc-<bold>3aa</bold> (88% ee) and a better yield (87%). Other substitution patterns in
the phenyl ring [<bold>9aa</bold> (<italic>o</italic>-Cl), <bold>10aa</bold> (<italic>p</italic>-Cl), <bold>11aa</bold> (<italic>p</italic>-NO<sub>2</sub>), and <bold>12aa</bold> (<italic>p</italic>-Me)] did not
improve the enantioselectivity of the process (up to 86% ee for <bold>10aa</bold>). According to an anion-binding activation mode, the
nature of the halide anion modified the reaction outcome. Hence, product <bold>8aa</bold> was isolated in lower enantioselectivity from reactions
performed using benzoyl bromide or fluoride as the acylating reagent
(73% and 30% ee, respectively). With the optimal conditions in hand,
the catalyst loading could be reduced to 5 mol % without compromising
yield or enantioselectivity. Next, the reactions of <bold>1a</bold> and <bold>2a</bold>, employing BzCl as the acylating reagent, were
investigated in more detail. A comparison of noncatalyzed <italic>vs</italic> catalyzed reaction kinetics revealed maximum differentiation
at the beginning of the process (from &#x02212;78 &#x000b0;C to &#x02212;30
&#x000b0;C), affording <bold>8aa</bold> in 75% NMR-yield after 6 h (vs
&#x0003c;5% in the background) (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>). Moreover, it was observed that the enantioselectivity
was slightly lower at the early stages (from &#x02212;78 to &#x02212;60
&#x000b0;C; 79% and 82% ee after 2 and 4 h, respectively), reaching a
maximum value of 88% ee after 6 h, which remained constant until the
end of the reaction. Therefore, a slow temperature gradient (from
&#x02212;78 &#x000b0;C to rt) was employed as optimal methodology for
further studies (<xref rid="sch3" ref-type="scheme">Scheme <xref rid="sch3" ref-type="scheme">3</xref></xref>). Different nucleophiles were initially tested.</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Screening of Organocatalysts and Optimization
of the Reaction Parameters<xref rid="t1fn1" ref-type="table-fn">a</xref></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ol3c03325_0007" id="fx1" position="float"/><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ol3c03325_0008" id="GRAPHIC-d14e369-autogenerated" position="float"/><table-wrap-foot><fn id="t1fn1"><label>a</label><p>Reactions performed at 0.1 mmol
scale.</p></fn><fn id="t1fn2"><label>b</label><p>Determined by <sup>1</sup>H NMR
using mesitylene as internal standard.</p></fn><fn id="t1fn3"><label>c</label><p>Determined by HPLC.</p></fn><fn id="t1fn4"><label>d</label><p>(<italic>R</italic>)-enantiomer.</p></fn></table-wrap-foot></table-wrap><fig id="sch2" position="float"><label>Scheme 2</label><caption><title>Optimization of Acylating Reagents</title><p id="s2fn1">(a) Reactions performed
at 0.2
mmol scale. Yields given for isolated products after chromatography.
ee&#x02019;s were determined by HPLC on chiral stationary phases. (b)
Reaction performed with 5 mol % of catalyst loading.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ol3c03325_0004" id="gr2" position="float"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Noncatalyzed vs catalyzed reaction kinetics. Reactions were performed
in MTBE with 5 mol % of catalyst from &#x02212;78 to 10 &#x000b0;C.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ol3c03325_0002" id="gr6" position="float"/></fig><fig id="sch3" position="float"><label>Scheme 3</label><caption><title>Substrate Scope</title><p id="s3fn1">(a) Reactions performed
at 0.2
mmol scale. (b) Reaction performed at 1 mmol scale. (c) 2.5 equiv
of <bold>2a</bold>. (d) 10 mol % of catalyst loading.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ol3c03325_0005" id="gr3" position="float"/></fig><p>Silyl ketene acetals bearing isopropyl, methyl, ethyl,
and benzyl
ester moieties (<bold>2a</bold>&#x02013;<bold>d</bold>) performed efficiently,
affording dihydrophthalazines (<italic>S</italic>)-<bold>8aa</bold>&#x02013;<bold>8ad</bold> in generally good yields (79&#x02013;89%)
and enantioselectivities (84&#x02013;90% ee). However, the use of <italic>tert</italic>-butyl ketene acetal <bold>2e</bold> led to a moderate
yield (49%) and lower enantioselectivity (78% ee).</p><p>Silyl enol
ethers derived from acetone and cyclohexanone were not
reactive in this transformation, while acetophenone-derived <bold>2f</bold> afforded <bold>8af</bold> in quantitative yield, albeit
in low enantioselectivity (8% ee). Finally, vinylogous reagent <bold>2g</bold> was also tolerated, affording <bold>8ag</bold> in good
yield (87%) with moderate enantioselectivity (55% ee). Next we carried
out the dearomatization reaction of different phthalazines using <bold>2a</bold> as a representative nucleophile. Within the symmetric series,
the product (<italic>S</italic>)-<bold>8ba</bold>, bearing an additional
fused aromatic ring, was obtained in 93% ee. 6,7-Disubstitution was
further evaluated: 6,7-dimethyl phthalazine (<bold>1d</bold>) proved
to be also a suitable substrate, affording the corresponding product
(<italic>S</italic>)-<bold>8da</bold> in excellent yield (91%) and
enantioselectivity (92%). On the other hand, the introduction of chloro
or alkoxy groups at these positions afforded products in poorer yields
and enantioselectivities [(<italic>S</italic>)-<bold>8ca</bold>, 54%,
46% ee; (<italic>S</italic>)-<bold>8ea</bold>, 77%, 40% ee]. The introduction
of oxygenated substituents near the reactive center had a negative
impact in the enantioselectivity. Thus, the dearomatization of 5,8-dimethoxyphthalazine
(<bold>1f</bold>) afforded (<italic>S</italic>)-<bold>8fa</bold> in
70% yield and 14% ee. Benzo[<italic>f</italic>]phthalazine <bold>1g</bold> afforded an inseparable mixture of regioisomers <bold>8ga</bold>/<bold>8ga</bold>&#x02032; (1:2) in good yield (88%) and moderate
to excellent ee values (59 and 90% ee, respectively). More interestingly,
C4-monosubstituted phthalazines afforded adducts (<italic>S</italic>)-<bold>8ha</bold>&#x02013;<bold>8pa</bold> in moderate-to-good yields
(50&#x02013;80%) and excellent enantioselectivities (89&#x02013;98%
ee), regardless of the nature of the substituents: chloro, cyano,
alkoxy groups, with various substitution patterns, heteroaryls (exemplified
by R = pyrrole), and a saturated heterocycle (R = morpholine). Finally,
the challenging substrate <bold>1q</bold>, bearing both phthalazine
and isoquinoline scaffolds, was evaluated. Remarkably, a double dearomatization
process involving the corresponding dibenzoyl bis-chloride allowed
the generation of two stereogenic centers in (<italic>S</italic>,<italic>S</italic>)-<bold>8qa</bold> with excellent stereocontrol [19:1 dr,
98% ee (major)] and 71% yield. Finally, the methodology was extended
to the dearomatization of pyridazine <bold>13a</bold>. Under the optimized
conditions, dihydropyridazines (<italic>S</italic>)-<bold>14aa</bold> and (<italic>S</italic>)-<bold>14ae</bold> were obtained in high
yields and moderate-to-good ee values of 52 and 85% ee, respectively.
It&#x02032;s worth noting that Bz-pyridazinium chloride was more soluble
in MTBE than the corresponding Bz-phthalazinium salt, thereby favoring
the competing background reaction (82% NMR-yield in absence of catalyst).
Additionally, other solvents and fixed temperatures (&#x02212;78 &#x000b0;C)
were unsuccessfully tested (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.orglett.3c03325/suppl_file/ol3c03325_si_001.pdf">Supporting Information</ext-link>). On the contrary, Troc-pyridazinium chloride was less soluble than
Bz-protected one and (<italic>S</italic>)-<bold>15aa</bold>, (<italic>S</italic>)-<bold>15ad</bold>, and (<italic>S</italic>)-<bold>15ae</bold> were synthesized with superior enantioselectivities (85&#x02013;95%
ee), albeit in moderate yields (46%, 55%, and 31%, respectively) even
when using 10 mol % of catalyst loadings. Remarkably, the best enantioselectivity
in this case was obtained when combined with <italic>tert</italic>-butyl ketene acetal <bold>2e</bold>, in contrast with the trend
observed in the dearomatization of <bold>1a</bold>. Finally, the synthetic
usefulness of dihydrophthalazines <bold>8</bold> was demonstrated
by accessing several selected targets (<xref rid="sch4" ref-type="scheme">Scheme <xref rid="sch4" ref-type="scheme">4</xref></xref>). Under standard hydrogenation conditions
[Pd(C)/ 1 atm (H<sub>2</sub>)], <bold>8aa</bold> underwent a chemoselective
hydrogenation of the C=N double bond to afford cyclic hydrazino
ester (<italic>S</italic>)-<bold>16</bold>. Under the same conditions,
(<italic>S</italic>)-<bold>8ka</bold> was efficiently transformed
into the phthalazone derivative (<italic>S</italic>)-<bold>17</bold> in high yields and without noticeable racemization.</p><fig id="sch4" position="float"><label>Scheme 4</label><caption><title>Transformations
of Dihydrophthalazines <bold>8</bold></title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ol3c03325_0006" id="gr4" position="float"/></fig><p>Additionally, 4-chloro substituted <bold>8ha</bold> was subjected
to Sonogashira coupling to yield product (<italic>S</italic>)-<bold>18</bold> (77%). To illustrate the synthetic potential of dihydrophthalazines <bold>8</bold> as cyclic &#x003b2;-hydrazino acid precursors, hydrolysis
of both the <sup><italic>i</italic></sup>Pr-ester and <italic>Bz</italic>-amide was performed under basic conditions [NaOH (3M), 37 &#x000b0;C].
Subsequent chemoselective <italic>O</italic>-alkylation through S<sub>N</sub>2 of 2-bromoacetophenone yielded <bold>19</bold> without compromising
the stereochemical integrity of the starting material (<bold>8aa</bold>). Additionally, milder basic conditions [NaOH (1M), from 0 &#x000b0;C
to rt] allowed selective saponification of the <sup><italic>i</italic></sup>Pr-ester. Peptide-type coupling of the corresponding carboxylic
acid with enantiopure <sc>l</sc>-phenylalanine ethyl ester, promoted
by HBTU, afforded (<italic>S,S</italic>)-<bold>20</bold> in good overall
yield (67%, 2 steps) and without a loss of enantiomeric purity (98%
of diastereomeric excess). Crystals of (<italic>S,S</italic>)-<bold>20</bold> suitable for X-ray diffraction analysis served to determine
the absolute <italic>S</italic> configuration of the newly created
stereogenic center in (<italic>S</italic>)-<bold>8la</bold>. Within
the Troc-protected series, the absolute <italic>S</italic> configuration
of dihydrophthalazine <bold>3aa</bold> and dihydropyridazine <bold>15aa</bold> was assigned by a chemical correlation. Assuming a uniform
stereochemical pathway, the absolute configurations of all other products
were assigned by analogy.</p><p>In summary, anion-binding catalysis
has enabled a three-component
enantioselective dearomatization reaction of phthalazines, employing
benzoyl chloride as the optimal acylating reagent and silyl ketene
acetals as nucleophiles. This general methodology afforded 1,2-dihydrophthalazines
in moderate-to-good yields and high enantioselectivities in most cases.
Subsequent derivatizations provide direct access to key building blocks
for the synthesis of dihydro- and tetrahydrophthalazines, phthalazones,
and piperazic acid homologues.</p></body><back><notes notes-type="data-availability" id="notes-1"><title>Data Availability Statement</title><p>The data underlying
this study are available in the published article and its <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.orglett.3c03325/suppl_file/ol3c03325_si_001.pdf">Supporting Information</ext-link>.</p></notes><notes id="notes-2" notes-type="si"><title>Supporting Information Available</title><p>The Supporting Information
is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.orglett.3c03325?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.orglett.3c03325</ext-link>.<list id="silist" list-type="simple"><list-item><p>Experimental details, optimizations, spectroscopic and
analytical data for new compounds, HPLC traces, crystallographic data
of (<italic>S</italic>,<italic>S</italic>)-<bold>20</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.orglett.3c03325/suppl_file/ol3c03325_si_001.pdf">PDF</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ol3c03325_si_001.pdf"><caption><p>ol3c03325_si_001.pdf</p></caption></media></supplementary-material></sec><notes notes-type="" id="notes-3"><title>Author Contributions</title><p>The manuscript
was written through contributions of all authors.</p></notes><notes notes-type="COI-statement" id="notes-4"><p>The authors
declare no competing financial interest.</p></notes><ack><title>Acknowledgments</title><p>We thank
the Spanish MICINN (grants PID2019-106358GB-C21,
PID2019-106358GB-C22, and PID2022-137888NB-I00), European FEDER funds,
and the Junta de Andaluc&#x000ed;a (grants P18-FR-3531, P18-FR-644,
and US-1262867) for financial support. We also thank Dr. Francisco
Jos&#x000e9; Fern&#x000e1;ndez de C&#x000f3;rdova (IIQ-CSIC) for X-ray
structure analysis.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Mathew</surname><given-names>T.</given-names></name>; <name><surname>Papp</surname><given-names>A. &#x000c1;.</given-names></name>; <name><surname>Paknia</surname><given-names>F.</given-names></name>; <name><surname>Fustero</surname><given-names>S.</given-names></name>; <name><surname>Prakash</surname><given-names>G. K. S.</given-names></name>
<article-title>Benzodiazines:
recent synthetic advances</article-title>. <source>Chem. Soc. Rev.</source>
<year>2017</year>, <volume>46</volume>, <fpage>3060</fpage>&#x02013;<lpage>3094</lpage>. <pub-id pub-id-type="doi">10.1039/C7CS00082K</pub-id>.<pub-id pub-id-type="pmid">28452390</pub-id>
</mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Zaib</surname><given-names>S.</given-names></name>; <name><surname>Khan</surname><given-names>I.</given-names></name>
<article-title>Synthetic and medicinal
chemistry of phthalazines: Recent developments,
opportunities and challenges</article-title>. <source>Bioorganic Chemistry</source>
<year>2020</year>, <volume>105</volume>, <elocation-id>104425</elocation-id><pub-id pub-id-type="doi">10.1016/j.bioorg.2020.104425</pub-id>.<pub-id pub-id-type="pmid">33157344</pub-id>
</mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>McNeely</surname><given-names>W.</given-names></name>; <name><surname>Wiseman</surname><given-names>L. R.</given-names></name>
<article-title>Intranasal azelastine.
A review of its efficacy in
the management of allergic rhinitis</article-title>. <source>Drugs</source>
<year>1998</year>, <volume>56</volume>, <fpage>91</fpage>&#x02013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.2165/00003495-199856010-00011</pub-id>.<pub-id pub-id-type="pmid">9664202</pub-id>
</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4a"><label>a</label><name><surname>Pelletier</surname><given-names>J. C.</given-names></name>; <name><surname>Hesson</surname><given-names>D. P.</given-names></name>; <name><surname>Jones</surname><given-names>K. A.</given-names></name>; <name><surname>Costa</surname><given-names>A.-M.</given-names></name>
<article-title>Substituted
1,2-Dihydrophthalazines: Potent, Selective, and Noncompetitive Inhibitors
of the AMPA Receptor</article-title>. <source>J. Med. Chem.</source>
<year>1996</year>, <volume>39</volume>, <fpage>343</fpage>&#x02013;<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1021/jm950740w</pub-id>.<pub-id pub-id-type="pmid">8558499</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="cit4b"><label> b</label><name><surname>Welch</surname><given-names>N. C.</given-names></name>; <name><surname>Lin</surname><given-names>W.</given-names></name>; <name><surname>Juranka</surname><given-names>P. F.</given-names></name>; <name><surname>Morris</surname><given-names>C. E.</given-names></name>; <name><surname>Stys</surname><given-names>P. K.</given-names></name>
<article-title>Traditional AMPA receptor antagonists partially block
Na<sub>v</sub>1.6-mediated persistent current</article-title>. <source>Neuropharmacology</source>
<year>2008</year>, <volume>55</volume>, <fpage>1165</fpage>&#x02013;<lpage>1171</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.07.015</pub-id>.<pub-id pub-id-type="pmid">18687344</pub-id>
</mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5a"><label>a</label><name><surname>Caspers</surname><given-names>P.</given-names></name>; <name><surname>Bury</surname><given-names>L.</given-names></name>; <name><surname>Gaucher</surname><given-names>B.</given-names></name>; <name><surname>Heim</surname><given-names>J.</given-names></name>; <name><surname>Shapiro</surname><given-names>S.</given-names></name>; <name><surname>Siegrist</surname><given-names>S.</given-names></name>; <name><surname>Schmitt-Hoffmann</surname><given-names>A.</given-names></name>; <name><surname>Thenoz</surname><given-names>L.</given-names></name>; <name><surname>Urwyler</surname><given-names>H.</given-names></name>
<article-title>In Vitro and In Vivo Properties of
Dihydrophthalazine Antifolates, a Novel Family of Antibacterial Drugs</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2009</year>, <volume>53</volume>, <fpage>3620</fpage>&#x02013;<lpage>3627</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00377-09</pub-id>.<pub-id pub-id-type="pmid">19546364</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="cit5b"><label> b</label><name><surname>Bowker</surname><given-names>K. E.</given-names></name>; <name><surname>Caspers</surname><given-names>P.</given-names></name>; <name><surname>Gaucher</surname><given-names>B.</given-names></name>; <name><surname>MacGowan</surname><given-names>A. P.</given-names></name>
<article-title>In Vitro
Activities of Three New Dihydrofolate Reductase Inhibitors against
Clinical Isolates of Gram-Positive Bacteria</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2009</year>, <volume>53</volume>, <fpage>4949</fpage>&#x02013;<lpage>4952</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00845-09</pub-id>.<pub-id pub-id-type="pmid">19738027</pub-id>
</mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6a"><label>a</label><name><surname>Bourne</surname><given-names>C. R.</given-names></name>; <name><surname>Bunce</surname><given-names>R. A.</given-names></name>; <name><surname>Bourne</surname><given-names>P. C.</given-names></name>; <name><surname>Berlin</surname><given-names>K. D.</given-names></name>; <name><surname>Barrow</surname><given-names>E. W.</given-names></name>; <name><surname>Barrow</surname><given-names>W. W.</given-names></name>
<article-title>Crystal structure of Bacillus anthracis
dihydrofolate reductase with the dihydrophthalazine-based trimethoprim
derivative RAB1 provides a structural explanation of potency and selectivity</article-title>. <source>Antimicrob. Agents Chemother.</source>
<year>2009</year>, <volume>53</volume>, <fpage>3065</fpage>&#x02013;<lpage>3073</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01666-08</pub-id>.<pub-id pub-id-type="pmid">19364848</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="cit6b"><label> b</label><name><surname>Bourne</surname><given-names>C. R.</given-names></name>; <name><surname>Wakeham</surname><given-names>N.</given-names></name>; <name><surname>Webb</surname><given-names>N.</given-names></name>; <name><surname>Nammalwar</surname><given-names>B.</given-names></name>; <name><surname>Bunce</surname><given-names>R. A.</given-names></name>; <name><surname>Berlin</surname><given-names>K. D.</given-names></name>; <name><surname>Barrow</surname><given-names>W. W.</given-names></name>
<article-title>The Structure and
Competitive Substrate Inhibition of Dihydrofolate Reductase from Enterococcus
Faecalis Reveal Restrictions to Cofactor Docking</article-title>. <source>Biochemistry</source>
<year>2014</year>, <volume>53</volume>, <fpage>1228</fpage>&#x02013;<lpage>1238</lpage>. <pub-id pub-id-type="doi">10.1021/bi401104t</pub-id>.<pub-id pub-id-type="pmid">24495113</pub-id>
</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>Attwood</surname><given-names>M.
R.</given-names></name>; <name><surname>Hassall</surname><given-names>C. H.</given-names></name>; <name><surname>Krohn</surname><given-names>A.</given-names></name>; <name><surname>Lawton</surname><given-names>G.</given-names></name>; <name><surname>Redshaw</surname><given-names>S.</given-names></name>
<article-title>The Design
and Synthesis of the Angiotensin Converting Enzyme Inhibitor Cilazapril
and Related Bicyclic Compounds</article-title>. <source>J. Chem. Soc.,
Perkin Trans. 1</source>
<year>1986</year>, <fpage>1011</fpage>&#x02013;<lpage>1019</lpage>. <pub-id pub-id-type="doi">10.1039/P19860001011</pub-id>.</mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8a"><label>a</label><name><surname>Haruyama</surname><given-names>H.</given-names></name>; <name><surname>Ohkuma</surname><given-names>Y.</given-names></name>; <name><surname>Nagaki</surname><given-names>H.</given-names></name>; <name><surname>Ogita</surname><given-names>T.</given-names></name>; <name><surname>Tamaki</surname><given-names>K.</given-names></name>; <name><surname>Kinoshita</surname><given-names>T.</given-names></name>
<article-title>Matlystatins,
new inhibitors of type
IV collagenases from Actinomadura atramentaria. III. Structure elucidation
of matlystatins A to F</article-title>. <source>J. Antibiot.</source>
<year>1994</year>, <volume>47</volume>, <fpage>1473</fpage>&#x02013;<lpage>1480</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.47.1473</pub-id>.</mixed-citation><mixed-citation publication-type="journal" id="cit8b"><label> b</label><name><surname>Leipoldt</surname><given-names>F.</given-names></name>; <name><surname>Santos-Aberturas</surname><given-names>J.</given-names></name>; <name><surname>Stegmann</surname><given-names>D. P.</given-names></name>; <name><surname>Wolf</surname><given-names>F.</given-names></name>; <name><surname>Kulik</surname><given-names>A.</given-names></name>; <name><surname>Lacret</surname><given-names>R.</given-names></name>; <name><surname>Popadi&#x00107;</surname><given-names>D.</given-names></name>; <name><surname>Keinh&#x000f6;rster</surname><given-names>D.</given-names></name>; <name><surname>Kirchner</surname><given-names>N.</given-names></name>; <name><surname>Bekiesch</surname><given-names>P.</given-names></name>; <name><surname>Gross</surname><given-names>H.</given-names></name>; <name><surname>Truman</surname><given-names>A. W.</given-names></name>; <name><surname>Kaysser</surname><given-names>L.</given-names></name>
<article-title>Warhead biosynthesis and the origin
of structural diversity in hydroxamate metalloproteinase inhibitors</article-title>. <source>Nat. Commun.</source>
<year>2017</year>, <volume>8</volume>, <fpage>1965</fpage><pub-id pub-id-type="doi">10.1038/s41467-017-01975-6</pub-id>.<pub-id pub-id-type="pmid">29213087</pub-id>
</mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9a"><label>a</label><name><surname>Yuan</surname><given-names>C.</given-names></name>; <name><surname>Liu</surname><given-names>H.</given-names></name>; <name><surname>Gao</surname><given-names>Z.</given-names></name>; <name><surname>Zhou</surname><given-names>L.</given-names></name>; <name><surname>Feng</surname><given-names>Y.</given-names></name>; <name><surname>Xiao</surname><given-names>Y.</given-names></name>; <name><surname>Guo</surname><given-names>H.</given-names></name>
<article-title>Cu(I)-Catalyzed
Highly
Enantioselective [3 + 3] Cycloaddition between Two different 1,3-Dipoles,
Phthalazinium Dicyanomethanides and Iminoester-Derived Azomethine
Ylides</article-title>. <source>Org. Lett.</source>
<year>2015</year>, <volume>17</volume>, <fpage>26</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1021/ol503169d</pub-id>.<pub-id pub-id-type="pmid">25522129</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="cit9b"><label> b</label><name><surname>Fern&#x000e1;ndez</surname><given-names>N.</given-names></name>; <name><surname>Carrillo</surname><given-names>L.</given-names></name>; <name><surname>Vicario</surname><given-names>J. L.</given-names></name>; <name><surname>Bad&#x000ed;a</surname><given-names>D.</given-names></name>; <name><surname>Reyes</surname><given-names>E.</given-names></name>
<article-title>Organocatalytic enantioselective
[3 + 2] cycloaddition using stable azomethine ylides</article-title>. <source>Chem. Commun.</source>
<year>2011</year>, <volume>47</volume>, <fpage>12313</fpage>&#x02013;<lpage>12315</lpage>. <pub-id pub-id-type="doi">10.1039/c1cc15671c</pub-id>.</mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Frisch</surname><given-names>K.</given-names></name>; <name><surname>Landa</surname><given-names>A.</given-names></name>; <name><surname>Saaby</surname><given-names>S.</given-names></name>; <name><surname>J&#x000f8;rgensen</surname><given-names>K. A.</given-names></name>
<article-title>Organocatalytic
Diastereo- and Enantioselective Annulation Reactions&#x02014;Construction
of Optically Active 1,2-Dihydroisoquinoline and 1,2-Dihydrophthalazine
Derivatives</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2005</year>, <volume>44</volume>, <fpage>6058</fpage>&#x02013;<lpage>6063</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200501900</pub-id>.</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><name><surname>Taylor</surname><given-names>M. S.</given-names></name>; <name><surname>Tokunaga</surname><given-names>N.</given-names></name>; <name><surname>Jacobsen</surname><given-names>E. N.</given-names></name>
<article-title>Enantioselective
Thiourea-Catalyzed
Acyl-Mannich Reactions of Isoquinolines</article-title>. <source>Angew.
Chem., Int. Ed.</source>
<year>2005</year>, <volume>44</volume>, <fpage>6700</fpage>&#x02013;<lpage>6704</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200502277</pub-id>.</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="book" id="cit12a"><label>a</label><source>Anion-Binding Catalysis</source>; <person-group person-group-type="editor"><name><surname>Garc&#x000ed;a Manche&#x000f1;o</surname><given-names>O.</given-names></name></person-group>, Ed.; <publisher-name>Wiley-VCH</publisher-name>: <publisher-loc>Weinheim</publisher-loc>, <year>2021</year>.</mixed-citation><mixed-citation publication-type="journal" id="cit12b"><label>b</label><name><surname>Brak</surname><given-names>K.</given-names></name>; <name><surname>Jacobsen</surname><given-names>E. N.</given-names></name>
<article-title>Asymmetric Ion-Pairing
Catalysis</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2013</year>, <volume>52</volume>, <fpage>534</fpage>&#x02013;<lpage>561</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201205449</pub-id>.</mixed-citation></ref><ref id="ref13"><note><p>For a review, see:</p></note><mixed-citation publication-type="journal" id="cit13a"><label>a</label><name><surname>Aleksiev</surname><given-names>M.</given-names></name>; <name><surname>Garc&#x000ed;a Manche&#x000f1;o</surname><given-names>O.</given-names></name>
<article-title>Enantioselective
dearomatization
reactions of heteroarenes by anion-binding organocatalysis</article-title>. <source>Chem. Commun.</source>
<year>2023</year>, <volume>59</volume>, <fpage>3360</fpage>&#x02013;<lpage>3372</lpage>. <pub-id pub-id-type="doi">10.1039/D2CC07101K</pub-id>.</mixed-citation><note><p>Selected examples, Isoquinolines:</p></note><note id="cit13b"><label>b</label><p>ref (<xref ref-type="bibr" rid="ref11">11</xref>).</p></note><mixed-citation publication-type="journal" id="cit13c"><label> c</label><name><surname>Matador</surname><given-names>E.</given-names></name>; <name><surname>Iglesias-Sig&#x000fc;enza</surname><given-names>J.</given-names></name>; <name><surname>Monge</surname><given-names>D.</given-names></name>; <name><surname>Merino</surname><given-names>P.</given-names></name>; <name><surname>Fern&#x000e1;ndez</surname><given-names>R.</given-names></name>; <name><surname>Lassaletta</surname><given-names>J. M.</given-names></name>
<article-title>Enantio- and Diastereoselective Nucleophilic Addition
of <italic>N</italic>-<italic>tert</italic>-Butylhydrazones to Isoquinolinium
Ions through Anion-Binding Catalysis</article-title>. <source>Angew.
Chem., Int. Ed.</source>
<year>2021</year>, <volume>60</volume>, <fpage>5096</fpage>&#x02013;<lpage>5101</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202012861</pub-id>.</mixed-citation><note><p>Quinolines:</p></note><mixed-citation publication-type="journal" id="cit13d"><label> d</label><name><surname>Zurro</surname><given-names>M.</given-names></name>; <name><surname>Asmus</surname><given-names>S.</given-names></name>; <name><surname>Beckendorf</surname><given-names>S.</given-names></name>; <name><surname>M&#x000fc;ck-Lichtenfeld</surname><given-names>C.</given-names></name>; <name><surname>Garc&#x000ed;a-Manche&#x000f1;o</surname><given-names>O.</given-names></name>
<article-title>Chiral Helical
Oligotriazoles: New Class of Anion-Binding Catalysts for the Asymmetric
Dearomatization of Electron-Deficient <italic>N</italic>-Heteroarenes</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2014</year>, <volume>136</volume>, <fpage>13999</fpage>&#x02013;<lpage>14002</lpage>. <pub-id pub-id-type="doi">10.1021/ja507940k</pub-id>.<pub-id pub-id-type="pmid">25211494</pub-id>
</mixed-citation><mixed-citation publication-type="journal" id="cit13e"><label> e</label><name><surname>G&#x000f3;mez-Mart&#x000ed;nez</surname><given-names>A.</given-names></name>; <name><surname>P&#x000e9;rez-Aguilar</surname><given-names>M. d. C.</given-names></name>; <name><surname>Piekarski</surname><given-names>D. G.</given-names></name>; <name><surname>Daniliuc</surname><given-names>C. G.</given-names></name>; <name><surname>Garc&#x000ed;a-Manche&#x000f1;o</surname><given-names>O.</given-names></name>
<article-title><italic>N</italic>,<italic>N</italic>-Dialkylhydrazones as Versatile Umpolung Reagents
in Enantioselective Anion-Binding Catalysis</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2021</year>, <volume>60</volume>, <fpage>5102</fpage>&#x02013;<lpage>5107</lpage>. <pub-id pub-id-type="doi">10.1002/anie.202013380</pub-id>.</mixed-citation><note><p>Pyridines:</p></note><mixed-citation publication-type="journal" id="cit13f"><label> f</label><name><surname>Garc&#x000ed;a-Manche&#x000f1;o</surname><given-names>O.</given-names></name>; <name><surname>Asmus</surname><given-names>S.</given-names></name>; <name><surname>Zurro</surname><given-names>M.</given-names></name>; <name><surname>Fischer</surname><given-names>T.</given-names></name>
<article-title>Highly Enantioselective
Nucleophilic Dearomatization of Pyridines by Anion-Binding Catalysis</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2015</year>, <volume>54</volume>, <fpage>8823</fpage><pub-id pub-id-type="doi">10.1002/anie.201502708</pub-id>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Fischer</surname><given-names>T.</given-names></name>; <name><surname>Bamberger</surname><given-names>J.</given-names></name>; <name><surname>Garc&#x000ed;a Manche&#x000f1;o</surname><given-names>O.</given-names></name>
<article-title>Asymmetric
nucleophilic dearomatization of diazarenes by anion-binding catalysis</article-title>. <source>Org. Biomol. Chem.</source>
<year>2016</year>, <volume>14</volume>, <fpage>5794</fpage>&#x02013;<lpage>5802</lpage>. <pub-id pub-id-type="doi">10.1039/C6OB00248J</pub-id>.<pub-id pub-id-type="pmid">27064711</pub-id>
</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal" id="cit15"><name><surname>Lehnherr</surname><given-names>D.</given-names></name>; <name><surname>Ford</surname><given-names>D. D.</given-names></name>; <name><surname>Bendelsmith</surname><given-names>A. J.</given-names></name>; <name><surname>Kennedy</surname><given-names>C. R.</given-names></name>; <name><surname>Jacobsen</surname><given-names>E. N.</given-names></name>
<article-title>Conformational
Control of Chiral Amido-Thiourea Catalysts Enables Improved Activity
and Enantioselectivity</article-title>. <source>Org. Lett.</source>
<year>2016</year>, <volume>18</volume>, <fpage>3214</fpage>&#x02013;<lpage>3217</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.6b01435</pub-id>.<pub-id pub-id-type="pmid">27294369</pub-id>
</mixed-citation></ref></ref-list></back></article>
